NGRN

gene
On this page

Also known as DSC92

Summary

NGRN (neugrin, neurite outgrowth associated, HGNC:18077) is a protein-coding gene on chromosome 15q26.1, encoding Neugrin (Q9NPE2). Plays an essential role in mitochondrial ribosome biogenesis. It is a selective cancer dependency (DepMap: 10.8% of cell lines).

Enables rRNA binding activity. Involved in mitochondrial ribosome assembly and positive regulation of mitochondrial translation. Located in several cellular components, including mitochondrion; mitotic spindle; and nuclear body.

Source: NCBI Gene 51335 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 51 total
  • Cancer dependency (DepMap): dependent in 10.8% of screened cell lines
  • MANE Select transcript: NM_001033088

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18077
Approved symbolNGRN
Nameneugrin, neurite outgrowth associated
Location15q26.1
Locus typegene with protein product
StatusApproved
AliasesDSC92
Ensembl geneENSG00000182768
Ensembl biotypeprotein_coding
OMIM616718
Entrez51335

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 6 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000331497, ENST00000379095, ENST00000411845, ENST00000885215, ENST00000885216, ENST00000939262, ENST00000961528

RefSeq mRNA: 1 — MANE Select: NM_001033088 NM_001033088

CCDS: CCDS32329

Canonical transcript exons

ENST00000379095 — 3 exons

ExonStartEnd
ENSE000014797509026567290265876
ENSE000016055349027118890272211
ENSE000036381449026628890266398

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 99.51.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 74.8267 / max 943.8670, expressed in 1822 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter IDTPM avgSamples expressed
14842960.42861822
14843011.07421781
1484321.4928946
1484330.5795253
1484340.5357155
1484370.5346263
1484310.181254

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
dorsolateral prefrontal cortexUBERON:000983499.51gold quality
superior frontal gyrusUBERON:000266199.46gold quality
Brodmann (1909) area 9UBERON:001354099.46gold quality
right frontal lobeUBERON:000281099.45gold quality
prefrontal cortexUBERON:000045199.44gold quality
frontal cortexUBERON:000187099.43gold quality
cerebral cortexUBERON:000095699.39gold quality
primary visual cortexUBERON:000243699.39gold quality
cortical plateUBERON:000534399.36gold quality
nucleus accumbensUBERON:000188299.35gold quality
hypothalamusUBERON:000189899.35gold quality
amygdalaUBERON:000187699.33gold quality
caudate nucleusUBERON:000187399.32gold quality
putamenUBERON:000187499.32gold quality
temporal lobeUBERON:000187199.30gold quality
anterior cingulate cortexUBERON:000983599.23gold quality
Ammon’s hornUBERON:000195499.21gold quality
ganglionic eminenceUBERON:000402399.21gold quality
brainUBERON:000095599.19gold quality
substantia nigraUBERON:000203899.19gold quality
gastrocnemiusUBERON:000138899.12gold quality
muscle of legUBERON:000138399.00gold quality
C1 segment of cervical spinal cordUBERON:000646998.92gold quality
ventricular zoneUBERON:000305398.91gold quality
cerebellar cortexUBERON:000212998.83gold quality
cerebellar hemisphereUBERON:000224598.83gold quality
cerebellumUBERON:000203798.82gold quality
right hemisphere of cerebellumUBERON:001489098.77gold quality
hindlimb stylopod muscleUBERON:000425298.72gold quality
skeletal muscle tissueUBERON:000113498.57gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-GEOD-75688yes1251.11
E-HCAD-10yes4.70
E-HCAD-5no15.41
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

22 targeting NGRN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-480399.9871.993117
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-651-3P99.9473.485177
HSA-MIR-605-3P99.8869.221833
HSA-MIR-221-3P99.8671.561329
HSA-MIR-222-3P99.8671.351337
HSA-MIR-442099.8270.081624
HSA-MIR-181B-2-3P99.8170.061646
HSA-MIR-181B-3P99.8170.061646
HSA-MIR-425599.7267.701541
HSA-MIR-1212499.6869.172700
HSA-MIR-451B99.5568.281380
HSA-MIR-4999-3P99.1165.55424
HSA-MIR-371A-5P99.0866.511914
HSA-MIR-140-3P99.0467.691324
HSA-MIR-6749-3P99.0065.731443
HSA-MIR-425797.8668.051190
HSA-MIR-493-3P97.5066.44731
HSA-MIR-60297.0961.68156

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 10.8% of screened cell lines.

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriongrnENSDARG00000061314
mus_musculusNgrnENSMUSG00000047084
rattus_norvegicusNgrnENSRNOG00000013553

Protein

Protein identifiers

NeugrinQ9NPE2 (reviewed: Q9NPE2)

Alternative names: Mesenchymal stem cell protein DSC92, Neurite outgrowth-associated protein, Spinal cord-derived protein FI58G

All UniProt accessions (2): A0A087WWE0, Q9NPE2

UniProt curated annotations — full annotation on UniProt →

Function. Plays an essential role in mitochondrial ribosome biogenesis. As a component of a functional protein-RNA module, consisting of RCC1L, NGRN, RPUSD3, RPUSD4, TRUB2, FASTKD2 and 16S mitochondrial ribosomal RNA (16S mt-rRNA), controls 16S mt-rRNA abundance and is required for intra-mitochondrial translation of core subunits of the oxidative phosphorylation system.

Subunit / interactions. Forms a regulatory protein-RNA complex, consisting of RCC1L, NGRN, RPUSD3, RPUSD4, TRUB2, FASTKD2 and 16S mt-rRNA. Interacts with 16S mt-rRNA; this interaction is direct.

Subcellular location. Nucleus. Secreted. Mitochondrion membrane.

Tissue specificity. Expressed at high levels in heart, brain and skeletal muscle. In brain, mainly expressed in neurons rather than glial cells.

Induction. Highly up-regulated in neuroblastostoma cells by retinoic acid treatment inducing neurite outgrowth.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Similarity. Belongs to the neugrin family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9NPE2-21yes
Q9NPE2-32

RefSeq proteins (1): NP_001028260* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR010487NGRN/Rrg9Family

Pfam: PF06413

UniProt features (15 total): glycosylation site 3, splice variant 2, sequence variant 2, sequence conflict 2, region of interest 2, signal peptide 1, chain 1, compositionally biased region 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NPE2-F168.870.35

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 41

Glycosylation sites (3): 158, 186, 268

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-6793080rRNA modification in the mitochondrion
R-HSA-9937008Mitochondrial mRNA modification

MSigDB gene sets: 152 (showing top): GCM_MAP4K4, GOBP_RIBOSOME_BIOGENESIS, GCM_GSPT1, GCM_ZNF198, GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_RIBOSOME_ASSEMBLY, GOBP_NEUROGENESIS, LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_ORGANELLE_ASSEMBLY, GCM_SUFU, GCM_CALM1, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS

GO Biological Process (4): neuron differentiation (GO:0030182), mitochondrial ribosome assembly (GO:0061668), positive regulation of mitochondrial translation (GO:0070131), cell differentiation (GO:0030154)

GO Molecular Function (3): RNA binding (GO:0003723), rRNA binding (GO:0019843), protein binding (GO:0005515)

GO Cellular Component (10): extracellular region (GO:0005576), nucleus (GO:0005634), nucleoplasm (GO:0005654), mitochondrion (GO:0005739), mitochondrial matrix (GO:0005759), nuclear body (GO:0016604), mitochondrial membrane (GO:0031966), intercellular bridge (GO:0045171), mitotic spindle (GO:0072686), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
rRNA processing in the mitochondrion1
Metabolism of RNA1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
intracellular membrane-bounded organelle2
mitochondrion2
cell differentiation1
generation of neurons1
ribosome assembly1
mitochondrial translation1
positive regulation of translation1
regulation of mitochondrial translation1
cellular developmental process1
nucleic acid binding1
RNA binding1
binding1
nuclear lumen1
cytoplasm1
intracellular organelle lumen1
nucleoplasm1
intracellular membraneless organelle1
mitochondrial envelope1
organelle membrane1
spindle1

Protein interactions and networks

STRING

576 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NGRNRPUSD4Q96CM3877
NGRNFASTKD2Q9NYY8861
NGRNRPUSD3Q6P087846
NGRNTRUB2O95900784
NGRNRCC1LQ96I51779
NGRNPTCD1O75127761
NGRNGTPBP10A4D1E9676
NGRNMRM3Q9HC36676
NGRNNRGNQ92686575
NGRNMTERF3Q96E29572
NGRNMTG2Q9H4K7564
NGRNMALSU1Q96EH3555
NGRNDDX28Q9NUL7514
NGRNMTERF4Q7Z6M4512
NGRNNSUN4Q96CB9476

IntAct

126 interactions, top by confidence:

ABTypeScore
NOP53RRP8psi-mi:“MI:0914”(association)0.640
LIN28AIGF2BP3psi-mi:“MI:0914”(association)0.640
GTF2H5NGRNpsi-mi:“MI:0915”(physical association)0.560
YOD1NGRNpsi-mi:“MI:0915”(physical association)0.560
ZNF324BZNF316psi-mi:“MI:0914”(association)0.530
RBM3PRMT5psi-mi:“MI:0914”(association)0.530
CIRBPPRMT5psi-mi:“MI:0914”(association)0.530
RPL7ZBTB24psi-mi:“MI:0914”(association)0.530
MRPL42GATCpsi-mi:“MI:0914”(association)0.530
RPL6MRPS14psi-mi:“MI:0914”(association)0.530
RBMXPTCD1psi-mi:“MI:0914”(association)0.530
DDX28PTCD1psi-mi:“MI:0914”(association)0.530
MRPL2GTPBP10psi-mi:“MI:0914”(association)0.530
ZC3HAV1KHNYNpsi-mi:“MI:0914”(association)0.530
HNRNPA1PTCD1psi-mi:“MI:0914”(association)0.530
IGF2BP3PTCD1psi-mi:“MI:0914”(association)0.530
NGRNRPL7psi-mi:“MI:0914”(association)0.530
RBM3AARS2psi-mi:“MI:0914”(association)0.530
MRPL13GTPBP10psi-mi:“MI:0914”(association)0.530
SRSF3CASC3psi-mi:“MI:0914”(association)0.530
NGRNDCTDpsi-mi:“MI:0915”(physical association)0.400

BioGRID (300): NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), WBSCR16 (Affinity Capture-MS), RPUSD3 (Affinity Capture-MS)

ESM2 similar proteins: A0JPN4, A2AKB4, A6NDY0, A6NP61, A7E321, B0BNE4, B1ASB6, O54824, O88286, O95931, P60924, Q14005, Q14154, Q1XFL1, Q3T1H2, Q3TYG6, Q3ZBR0, Q49AM3, Q4R2Z8, Q4R747, Q4VXA5, Q5R7E7, Q5SU73, Q5SXM2, Q5SYB0, Q5XFR0, Q6NVP7, Q6P1D7, Q6ZUX3, Q7Z572, Q7ZXB8, Q80VM8, Q8BG34, Q8BIY3, Q8BLK9, Q8BP86, Q8IY92, Q8K124, Q93075, Q96FV0

Diamond homologs: A1C6R8, A1DHD8, A2QCR5, A3LTV8, A5DKF1, A5DZ02, A6ZRM7, A7EJ50, A7TIC4, B0XSW5, B2W722, B3LP57, B5VQJ9, B6HDT2, B6QGW6, B8MLF7, B8NHF2, C0SC25, C1GIF2, C4JXN2, C4R331, C5DD31, C5DTR1, C5FNG9, C5GEF3, C5JS82, C5PBQ8, C7GPE4, C8ZG19, D1ZQ10, D4AKN8, D4DHC4, E3L408, E3REX1, E4UQC3, O14211, P0C8Z6, P40156, Q0CYR5, Q0TY47

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 112 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Mitochondrial translation initiation1527.2×6e-16
Mitochondrial translation elongation1527.2×6e-16
Mitochondrial ribosome-associated quality control1526.3×6e-16
Mitochondrial translation1223.6×4e-12
Mitochondrial translation termination1523.5×3e-15
Translation1412.4×2e-10
Transport of Mature mRNA derived from an Intron-Containing Transcript510.9×2e-03
Processing of Capped Intron-Containing Pre-mRNA910.6×6e-06

GO biological processes:

GO termPartnersFoldFDR
negative regulation of mRNA splicing, via spliceosome536.8×3e-05
mitochondrial translation1728.4×8e-18
positive regulation of mRNA splicing, via spliceosome526.1×1e-04
regulation of alternative mRNA splicing, via spliceosome614.1×3e-04
mRNA transport512.7×3e-03
translation1211.9×9e-08
RNA processing510.5×5e-03
mRNA splicing, via spliceosome97.9×2e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

51 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance41
Likely benign3
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

745 predictions. Top by Δscore:

VariantEffectΔscore
15:90265866:G:GTdonor_gain1.0000
15:90266394:A:Gdonor_gain0.9900
15:90265856:G:GTdonor_gain0.9800
15:90265874:G:GTdonor_gain0.9800
15:90265874:GAGGT:Gdonor_loss0.9800
15:90265876:GGTAC:Gdonor_loss0.9800
15:90265877:G:Tdonor_loss0.9800
15:90266286:A:AGacceptor_gain0.9800
15:90266287:G:GGacceptor_gain0.9800
15:90265870:TGGAG:Tdonor_gain0.9700
15:90265874:GAG:Gdonor_gain0.9700
15:90266287:GC:Gacceptor_gain0.9700
15:90266394:ATACG:Adonor_loss0.9700
15:90266396:ACG:Adonor_loss0.9700
15:90266397:CGGTG:Cdonor_loss0.9700
15:90266398:GGTGA:Gdonor_loss0.9700
15:90266399:G:GGdonor_gain0.9700
15:90266399:GTGAG:Gdonor_loss0.9700
15:90266400:TGAGA:Tdonor_loss0.9700
15:90266401:GAGAC:Gdonor_loss0.9700
15:90266410:GA:Gdonor_gain0.9700
15:90266692:GCA:Gdonor_gain0.9700
15:90265852:A:Tdonor_gain0.9600
15:90266287:GCA:Gacceptor_gain0.9600
15:90266287:GCACC:Gacceptor_gain0.9600
15:90266403:G:Cdonor_loss0.9600
15:90266693:C:Tdonor_gain0.9600
15:90267618:GGC:Gdonor_gain0.9600
15:90267619:GCG:Gdonor_gain0.9600
15:90265871:GGAGA:Gdonor_gain0.9500

AlphaMissense

1885 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
15:90271243:T:CF111L0.994
15:90271245:T:AF111L0.994
15:90271245:T:GF111L0.994
15:90271232:T:CL107S0.990
15:90271235:C:AA108D0.984
15:90271193:T:CL94S0.981
15:90266395:T:CI91T0.980
15:90271216:T:AW102R0.979
15:90271216:T:CW102R0.979
15:90271288:T:CF126L0.978
15:90271290:T:AF126L0.978
15:90271290:T:GF126L0.978
15:90271274:T:AV121D0.972
15:90271234:G:CA108P0.971
15:90266398:G:CR92P0.967
15:90271244:T:CF111S0.965
15:90271265:T:AI118N0.965
15:90271218:G:CW102C0.964
15:90271218:G:TW102C0.964
15:90271750:T:CF280L0.963
15:90271752:C:AF280L0.963
15:90271752:C:GF280L0.963
15:90271272:A:CR120S0.962
15:90271272:A:TR120S0.962
15:90266366:G:CR81S0.958
15:90266366:G:TR81S0.958
15:90266382:G:CA87P0.957
15:90271250:T:AV113D0.957
15:90271243:T:AF111I0.954
15:90266395:T:AI91K0.948

dbSNP variants (sampled 300 via entrez): RS1000280670 (15:90267815 A>G), RS1000284543 (15:90268000 CGTTTGTTT>C,CGTTT,CGTTTGTTTGTTT), RS1000696502 (15:90268020 G>A), RS1003068902 (15:90269924 A>G), RS1003409078 (15:90271312 C>A), RS1003452079 (15:90269672 C>A,G,T), RS1003684193 (15:90263726 C>A,T), RS1004854797 (15:90265293 A>G,T), RS1005473924 (15:90267116 C>G), RS1006041786 (15:90271905 T>C), RS1006365562 (15:90265950 G>A,T), RS1006469759 (15:90265649 G>A,T), RS1006948112 (15:90270398 C>T), RS1007260590 (15:90267779 A>G), RS1007486289 (15:90264497 C>G,T)

Disease associations

OMIM: gene MIM:616718 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST009597_254Multiple sclerosis1.000000e-12
GCST012481_11Cerebral amyloid angiopathy in Alzheimer’s disease3.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

33 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression, decreases methylation3
Cyclosporineincreases expression2
aristolochic acid Iincreases expression1
bisphenol Faffects cotreatment, decreases expression1
triphenyl phosphateaffects expression1
bisphenol Aaffects expression1
potassium chromate(VI)increases expression, affects cotreatment1
epigallocatechin gallateincreases expression, affects cotreatment1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
perfluoro-n-nonanoic acidincreases expression1
K 7174increases expression1
abrineincreases expression1
picoxystrobindecreases expression1
Resveratrolaffects cotreatment, increases expression1
Arsenic Trioxideincreases expression1
Acetaminophenincreases expression1
Air Pollutants, Occupationalaffects expression1
Cadmiumincreases abundance, increases expression1
Dexamethasonedecreases expression, affects cotreatment1
Indomethacinaffects cotreatment, decreases expression1
Leadaffects expression1
Plant Extractsaffects cotreatment, increases expression1
Ribonucleotidesaffects binding1
Rotenonedecreases expression1
Sarindecreases expression1
Tobacco Smoke Pollutionincreases expression1
Zincdecreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, decreases expression1
Aflatoxin B1increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cerebral amyloid angiopathy